Nie et al. compared efficiency and toxicities of I-Pl and IV infusion of bevacizumab for MPE mediated from non-squamous NSCLC in order to reveal the relationship between serum VEGF levels and outcomes of pleural effusion in NSCLC. This evidence concerns the gene VEGFA and non-small cell lung carcinoma.